Veru Inc (VERU)
1.335
-0.02
(-1.11%)
USD |
NASDAQ |
May 10, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Veru Revenue (Annual): 16.30M for Sept. 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
September 30, 2023 | 16.30M |
September 30, 2022 | 39.35M |
September 30, 2021 | 61.26M |
September 30, 2020 | 42.59M |
September 30, 2019 | 31.80M |
September 30, 2018 | 15.86M |
September 30, 2017 | 13.66M |
September 30, 2016 | 22.13M |
September 30, 2015 | 32.60M |
September 30, 2014 | 24.49M |
September 30, 2013 | 31.46M |
September 30, 2012 | 35.03M |
September 30, 2011 | 18.57M |
September 30, 2010 | 22.22M |
September 30, 2009 | 27.54M |
September 30, 2008 | 25.63M |
September 30, 2007 | 19.32M |
September 30, 2006 | 14.82M |
Date | Value |
---|---|
September 30, 2005 | 11.16M |
September 30, 2004 | 8.982M |
September 30, 2003 | 9.046M |
September 30, 2002 | 8.416M |
September 30, 2001 | 6.716M |
September 30, 2000 | 5.767M |
September 30, 1999 | 4.716M |
September 30, 1998 | 5.50M |
September 30, 1997 | 2.90M |
September 30, 1996 | 2.10M |
September 30, 1995 | 2.20M |
September 30, 1994 | 16.20M |
September 30, 1993 | 12.50M |
September 30, 1992 | 11.20M |
September 30, 1991 | 13.10M |
September 30, 1990 | 10.70M |
April 30, 1990 | 5.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
16.30M
Minimum
2023
61.26M
Maximum
2021
38.26M
Average
39.35M
Median
2022
Revenue (Annual) Benchmarks
EyePoint Pharmaceuticals Inc | 46.02M |
INVO Bioscience Inc | 3.021M |
Bio-Path Holdings Inc | -- |
Aileron Therapeutics Inc | -- |
ProKidney Corp | -- |